Comparison of Nutritional Information With Iron-succinate Supplementation in Healthy Women
Fe-Health
Fe-minine Health and Exercise
1 other identifier
interventional
80
1 country
1
Brief Summary
The primary aim of the current study is to evaluate the effects of dietary nutritional advice with regards to iron rich food sources or a daily oral supplement of 100 mg ferrous iron succinate in 80 menstruating, healthy women aged 20-40 years for 8 weeks. The study will use a randomized controlled non-blinded design, and 80 healthy women aged 20-40 years whom regularly exercise will be included. Data collection will be made through online, standardized forms using the digital platform REDCap 13.1.28 (Vanderbilt University, Nashville, TN, USA). Study personnel will register laboratory and body weight results through the same system. Participants will be randomized 1:1 to either follow written dietary recommendations to increase their dietary iron intake, or to use a daily oral supplement of 100 mg of iron succinate. Study parameters are blood tests (fasting blood samples will be collected by a licensed laboratory: serum iron, serum transferrin, serum transferrin saturation, serum ferritin, and serum soluble transferrin receptor, blood status (hemoglobin, MCV, MCH, MCHC, thrombocytes, leukocytes), and plasma high-sensitivity C-reactive protein (hsCRP) and Body height and weight as well as questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2024
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedFirst Posted
Study publicly available on registry
October 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedOctober 18, 2024
October 1, 2024
2 months
September 15, 2024
October 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ferritin blood test
Change (increase) in serum ferritin levels.
From enrollment to end of test period, 8 weeks.
Secondary Outcomes (2)
Changes in measures of hemoglobin
From enrollment to end of test period, 8 weeks.
Sense of well being and subjective sense of health
From enrollment to end of test period, 8 weeks.
Study Arms (2)
Nutritional information
ACTIVE COMPARATORWritten information about food with high iron content.
100mg iron-succinate per day as a pill.
EXPERIMENTALParticipants get 56 pills of 100mg iron-succinate to take one/day for 8 weeks.
Interventions
Written nutritional information about food with high content of iron.
100 mg of Iron-succinate per day.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Linkoepinglead
- Primary Health Care Center, Region Östergötlandcollaborator
- Linkoeping Universitycollaborator
Study Sites (1)
Faculty of Medicine and Health Sciences Linköping University
Linköping, 58185, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fredrik H Nyström, MD PhD Professor
Linkoeping University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD PhD full professor, senior consultant in internal medicine
Study Record Dates
First Submitted
September 15, 2024
First Posted
October 18, 2024
Study Start
October 15, 2024
Primary Completion
December 1, 2024
Study Completion
January 1, 2025
Last Updated
October 18, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share
For ethical reasons such data will not be shared.